NHS News and Press, Neuberger Berman High Yield Strategies Fund From 05/22/23

2023-05-22 13:49:22 ET Summary Quick notes on Neuberger Berman High Yield Strategies' rights offering this year. Our suggestion is to sell before the ex-rights date and rebuy after the offering. Those holding should subscribe (unless the discount is wider than -11%) or sell th...

2023-05-01 09:17:27 ET Neuberger Berman High Yield Strategies ( NYSE: NHS ) declares $0.0905/share monthly dividend , in line with previous. Forward yield 11.97% Payable May 31; for shareholders of record May 12; ex-div May 11. See NHS Dividend Scorecard, Yie...

2023-04-30 01:44:27 ET Summary Discounts/premiums are one of the most important metrics for CEFs that can provide opportunities for investors. Closed-end funds often see expanded discounts during volatile years, which we experienced in 2022. Volatility has been coming down in ...

Summary 0 out of 22 closed-end fund sectors positive on price and 3 out of 22 sectors positive on NAV last week. KIO rights offering results. MLPs are the most discounted CEF sector. Author’s note: This article was released to CEF/ETF Income Laboratory members on ...

Summary NHS is a fixed income closed end fund. The fund focuses on U.S. high yield bonds, which represent 88% of the portfolio. What sets this fund apart in the HY CEF space is its very high leverage ratio of 42%, which magnifies its total returns. The fund is up over 23% since ...

Despite last week’s market pop, there are still plenty of terrific dividend buys out there. But don’t waste your time with lame payers like General Mills (GIS), with its 2.7% yield. Or the miserly 2.2% you get from a so-called “Dividend Aristocrat” like ...

Summary NHS is a fixed income closed end fund. Over 88% of the fund holdings are fixed rate high yield bonds. The CEF runs a very high leverage ratio of 43%. All of the CEF's liabilities are term funded through senior notes and preferred shares. This article covers CEF...

Summary For the first month in three, equity CEFs (+4.49%) on average witnessed plus-side returns, while their fixed income CEF cohorts (-5.07%) suffered a third month of declines in October. Only 17% of all CEFs traded at a premium to their NAV at month end, with 24% of equity CE...

Summary Imagine stocks or funds that pay out their dividends once a month! Unlike waiting for quarterly, semi-annual or (ugh) annual payouts, your angst waiting for money is reduced by 300%, or more! These October U.S. exchange-traded monthly-paid (MoPay) dividends, upsides, and n...

Fixed income and equity CEFs posted their best monthly NAV-based returns since November 2020. For the second month in three, equity CEFs on average witnessed plus-side returns, climbing 5.75% on a NAV basis for July. While for the first month in seven, fixed income CEFs posted ret...